Role of nucleosome remodeling in neurodevelopmental and intellectual disability disorders by Alberto J. López & Marcelo A. Wood
REVIEW
published: 23 April 2015
doi: 10.3389/fnbeh.2015.00100






University of Alabama at Birmingham,
USA
James Stafford,
NYU Lagone Medical, USA
*Correspondence:
Marcelo A. Wood,
Department of Neurobiology and
Behavior, University of California Irvine,
301 Qureshey Research Lab, Irvine,
CA 92697-3800, USA
mwood@uci.edu
Received: 10 February 2015
Accepted: 06 April 2015
Published: 23 April 2015
Citation:
López AJ and Wood MA (2015) Role
of nucleosome remodeling in
neurodevelopmental and intellectual
disability disorders.
Front. Behav. Neurosci. 9:100.
doi: 10.3389/fnbeh.2015.00100
Role of nucleosome remodeling in
neurodevelopmental and intellectual
disability disorders
Alberto J. López and Marcelo A. Wood*
Department of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory, University of California
Irvine, Irvine, CA, USA
It is becoming increasingly important to understand how epigenetic mechanisms
control gene expression during neurodevelopment. Two epigenetic mechanisms that
have received considerable attention are DNA methylation and histone acetylation.
Human exome sequencing and genome-wide association studies have linked several
neurobiological disorders to genes whose products actively regulate DNA methylation
and histone acetylation. More recently, a third major epigenetic mechanism, nucleosome
remodeling, has been implicated in human developmental and intellectual disability (ID)
disorders. Nucleosome remodeling is driven primarily through nucleosome remodeling
complexes with specialized ATP-dependent enzymes. These enzymes directly interact
with DNA or chromatin structure, as well as histone subunits, to restructure the shape
and organization of nucleosome positioning to ultimately regulate gene expression. Of
particular interest is the neuron-specific Brg1/hBrm Associated Factor (nBAF) complex.
Mutations in nBAF subunit genes have so far been linked to Coffin-Siris syndrome (CSS),
Nicolaides-Baraitser syndrome (NBS), schizophrenia, and Autism Spectrum Disorder
(ASD). Together, these human developmental and ID disorders are powerful examples of
the impact of epigenetic modulation on gene expression. This review focuses on the new
and emerging role of nucleosome remodeling in neurodevelopmental and ID disorders
and whether nucleosome remodeling affects gene expression required for cognition
independently of its role in regulating gene expression required for development.
Keywords: epigenetics, nucleosome remodeling, autism spectrum disorders (ASD), intellectual disability, BAF53b,
rubinstein-taybi syndrome, coffin-siris syndrome, nicolaides-baraitser syndrome
Introduction
It has long been understood that gene expression is critical not only for neural development, but
also for healthy cognition in the adult. The temporally and spatially specific regulation of this gene
expression is critical for the aforementioned processes to occur. One basic regulatory element of
gene expression is the spatial organization of DNA, extremely compacted into chromatin. Nucleo-
somes are the basic subunit of chromatin and consist of approximately 147 DNA base pairs spooled
around a histone octamer. These nucleosomes can fluctuate between various levels of compaction,
and their state is a critical and limiting factor in allowing transcription machinery to access genes of
interest. Recent work has shown that various epigenetic mechanisms can regulate gene expression
by altering chromatin compaction as well as providing a signal integration platform necessary to
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coordinate large protein complexes for transcriptional reg-
ulation. These activities have a major role in both where
and when necessary genes are expressed (Barrett and Wood,
2008; Hargreaves and Crabtree, 2011; Rando and Winston,
2012).
Such epigenetic mechanisms include DNA methylation, his-
tone modifications (including acetylation, ubiquitination, and
phosphorylation), and nucleosome remodeling. The majority
of attention in neuroscience has been given to histone mod-
ifications and DNA methylation as regulators of transcrip-
tion. Deficits in either of the aforementioned mechanisms can
have profound effects on development and adult cognition.
For instance, identified mutations in methyl CpG binding pro-
tein 2 (MECP2) are known to cause Rett syndrome (Rett,
1966; Amir et al., 1999; Trappe et al., 2001; Guy et al., 2007;
McGraw et al., 2011; Chao and Zoghbi, 2012; Katz et al.,
2012; Heckman et al., 2014), whereas mutations in CREB bind-
ing protein (CBP) cause Rubinstein-Taybi syndrome. (Rubin-
stein and Taybi, 1963; Padfield et al., 1968; Hennekam et al.,
1992; Petrif et al., 1995; Cantani and Gagliesi, 1998; Alar-
cón et al., 2004; Verhoeven et al., 2009; Wang et al., 2010;
Suzuki et al., 2013; Park et al., 2014). Yet, nucleosome remod-
eling remains a relatively unexplored mechanism of neural
epigenetics.
Nucleosome remodeling is driven by nucleosome remodel-
ing complexes (NRCs). These nuclear enzyme complexes are
capable of actively sliding, ejecting, or completely restructur-
ing nucleosome structure (Workman and Kingston, 1998; Li
et al., 2007). As such, NRCs, specifically the neuron-specific
Brg1/hBrm Associated Factor (nBAF) complex, can have pro-
found effects on neuron-specific gene expression throughout
development and adulthood. Recently, human exome sequenc-
ing studies have linked mutations in BAF complex genes
to intellectual disability (ID) disorders and Autism Spec-
trum Disorder (ASD), increasing the significance and impor-
tance of understanding the dynamics of nBAF gene regula-
tion (Halgren et al., 2012; Santen et al., 2012a, 2013; Tsu-
rusaki et al., 2012; Van Houdt et al., 2012; Parikshak et al.,
2013; Helsmoortel et al., 2014; Miyake et al., 2014; Vandeweyer
et al., 2014). This review will focus on the role of nBAF
in gene regulation throughout development and adult neural
function.
It is important to distinguish nucleosome remodeling from
other forms of epigenetic mechanisms. Nucleosome (chromatin)
remodeling specifically refers to the ATP-dependent enzymatic
complexes (e.g., nBAF, SWI/SNF, INO80, ISWI, NURD) that are
involved in nucleosome mobility underlying transcriptional reg-
ulation. In neuroscience however, the term chromatin remodel-
ing is misused as a catch-all phrase (Barrett and Wood, 2008).
Chromatin remodeling is distinct from chromatin modifica-
tion, which refers to histone modification (histone acetylation,
phosphorylation, methylation, etc). Chromatin modification has
two primary functions including the regulation of DNA-histone
interaction as well as serving as a signal transduction integra-
tion platform for coordinate gene regulation (Barrett and Wood,
2008).
Nucleosome Remodeling in Eukaryotic
Development
Nucleosome remodeling, a well-studied mechanism in yeast
genetics and cancer biology, is relatively uninvestigated in
neuroscience. Nucleosome remodeling is driven primarily
through ATP-dependent NRCs capable of altering nucleosome
structure by repositioning nucleosomes along chromosomal
DNA, ejecting histones, or enabling histone variants to be
interchanged within the DNA/protein interactions (Varga-weisz,
2001; Teif and Rippe, 2009; Hargreaves and Crabtree, 2011;
Vogel-Ciernia and Wood, 2014). Although a core ATPase
enzyme is common to all complexes, the known NRCs are
unique in their subunit composition, catalytic domains, complex
function, and recruited proteins. There are various families of
these protein complexes, including the well-studied NuRD and
SWI/SNF complexes.
The SWI/SNF complex is characterized by the well conserved
DNA-dependent ATPase domain and the single bromodomain;
this bromodomain is known to interact with acetylated histones
and stabilize SWI/SNF-histone interactions (Hassan et al., 2001;
Rando andWinston, 2012). These SWI/SNF-histone interactions
are key in enabling the complex to drive nucleosome remod-
eling. The most commonly proposed mechanisms by which
SWI/SNF is believed to remodel nucleosomes is referred to as the
“DNA looping” or “reptation” model (Whitehouse et al., 1999;
Van Holde and Yager, 2003). It proposes that SWI/SNF breaks
histone-DNA interactions to form amicro-DNA loop using a tor-
sional domain. This loop is forced to travel the length of DNA
along the nucleosome by a tracking domain in the SWI/SNF com-
plex which causes the nucleosome to slide as a result. (Havas et al.,
2000; Becker and Hörz, 2002; Zhang et al., 2006; Zofall et al.,
2006; Tang et al., 2010). Additionally, SWI/SNF complexes, in
conjunction with histone chaperone proteins, are known to eject
histones completely from nucleosome complexes (Boeger et al.,
2003; Lorch et al., 2006; Tang et al., 2010).
The SWI/SNF complex has been shown to regulate transcrip-
tion in a relatively large percentage of yeast genes. Several of
the genes that fall under SWI/SNF regulation are critical for
M-phase transcription (Krebs et al., 2000; Rando and Winston,
2012). For example, the HO endonuclease induces yeast mating-
type switching through a double strand break. It has been shown
that expression of the Ho gene is dependent on SWI proteins
1-6 for activation (Haber and Garvik, 1977; Stern et al., 1984;
Breeden and Nasmyth, 1987; Nasmyth and Shore, 2011). Ele-
gant genetic studies have shown that SWI/SNF interacts with
histone acetyltransferase (HAT) enzymes to regulate gene expres-
sion including the Ho gene. For example, when Snf2 mutations
are introduced to Gcn5 mutants (a HAT enzyme in the SAGA
HAT complex), offspring are developmentally inviable (Pollard
and Peterson, 1997; Rando and Winston, 2012). Additionally,
SWI/SNF activity shares gene targets with SAGA HAT activity,
includingHo. SWI/SNF and GCN5 are activated during the latter
stages of mitosis, where SWI/SNF is recruited to the Ho pro-
moter prior to, and is required for, GCN5 HAT activity (Cosma
et al., 1999; Krebs et al., 1999, 2000; Varga-weisz, 2001; Mitra
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et al., 2006). Thus, SWI/SNF regulation of chromatin compaction
states produce temporally selective gene expression profiles that
function as switches for the developing and reproducing yeast.
Understanding that these mechanisms (such as histone modifi-
cations and nucleosome remodeling) do not occur in isolation
from, but rather in conjunction with, each other is a fundamental
principle to guide further research in dynamic gene regulation.
For example, the combinatorial activity of HATs and NRCs
strongly suggests that both histone modification and chromatin
remodeling are necessary for proper genetic regulation to occur.
The only known NRC to have both deacetylase and ATP-
dependent nucleosome remodeling is the Nucleosome Remod-
eling Deacetylase (NuRD) complex (Xue et al., 1998; Denslow
and Wade, 2007; Zhang and Li, 2010). The Mi-2/NuRD complex
is composed of seven protein subunits: HDAC1, HDAC2 (his-
tone deacetylases), RbAp46, RbAp48 (responsible for histone-
binding), an MTA protein, MBD, and a CHD (Zhang et al., 1999;
Ahringer, 2000). The ATPase functions of the NuRD complex
are specifically engaged when the complex interacts with chro-
matin, and are inactive when exposed to isolated DNA or his-
tones (Wade et al., 1998; Brehm et al., 2000; Wang and Zhang,
2001). It is likely that NuRD-mediated nucleosome remodeling is
similar to that observed with Mi-2 alone, whose ATPase activity
is DNA- and nucleosome-stimulated (Brehm et al., 2000; Wang
and Zhang, 2001; Becker and Hörz, 2002). This ATPase activity
has been shown to promote nucleosome sliding (Aoyagi et al.,
2003; Lusser et al., 2005; Bao and Shen, 2007). Moreover, MBD
subunits of the NuRD complex are capable of recognizing and
binding methylated DNA (Hendrich and Bird, 1998; Wade et al.,
1999; Zhang et al., 1999; Bowen et al., 2004). This strongly sug-
gests that MBD allows the NuRD complex to maintain a level of
gene repression on gene targets already tagged for transcriptional
silencing.
Similar to other NRCs, NuRD complexes have a vital role in
regulating gene expression with temporal precision. For example,
the drosophila homolog, dMi-2, has been shown to interact with
the DNA-binding protein Hb to maintain repression of specific
Hox genes. Double mutant animals ofHb and dMi-2 show loss of
Hox gene repression (Kehle et al., 1998). Moreover, recruitment
of NuRD to chromatin is dependent on transcription factor bind-
ing in Drosophila (Reddy et al., 2010), specifically TTK69, which
is considered to be a transcriptional repressor.
The role of NuRD throughout development is also observed
in mammals. Homozygous deletion of Mbd3 in mice results
in embryonic lethality, while Mbd2−/− mice show failed gene
repression (Hendrich et al., 2001). The NuRD complex is also
highly expressed throughout mammalian cell types, where it also
has been shown to have gene specificity, rather than function-
ing as a global gene repressor (Kaji et al., 2006; McDonel et al.,
2009). For example, in vitro Mbd−/− cell lines show halted differ-
entiation. Other NuRD core subunits were shown to be reduced,
such as MTA1 and MTA2, and were no longer co-precipitated
from nuclear extracts. This suggests that MBD3 is a necessary
component for NuRD complex stabilization. Interestingly, only
a limited pool of genes were shown to be misregulated in these
cells lackingMbd3, particularly Pramel7 and Pramel6 (Kaji et al.,
2006). The NuRD complex is also known to selectively target the
Htra1 promoter and deacetylate H3K27 at this promoter. Specif-
ically, this complex has been shown to bind directly to partic-
ular histones in a trimethylated state, including H3K4me3 and
H3K27me3. ES cells lacking Mbd3 show decreased trimethyla-
tion and increased acetylated H3K27 compared to wild type cells,
providing further evidence that NuRD functions tomaintain spe-
cific gene repression (Reynolds et al., 2011). NuRD subunits are
critical in the adult as well. Loss of NuRD related genes, partic-
ularly Hdac1, Mta3, Chd3, or Chd4, leads to chromatin defects
similar to those observed throughout aging (Pegoraro et al.,
2009). Further evidence suggesting NuRD is able to coordinately
regulate histonemodification patterns (e.g., histone deacetylation
and histone demethylation) with nucleosome remodeling comes
from the relatively new discovery that lysine-specific demethylase
(LSD1) and JARID1B are subunits of the NuRD complex (Wang
et al., 2009; Li et al., 2011). LSD1 is a demethylase that removes
mono- and di-methyl groups from H3 and H4 and may work
synergistically with HDAC1/2 to generate or maintain a repres-
sive chromatin environment (Shi et al., 2005). JARID1B is a his-
tone demethylase that also targets H3 (H3K4 more specifically)
and may work in a serial manner with LSD1 in the regulation
of histone demethylation (Li et al., 2011). These subunits of the
NuRD complex highlight how subunit specific composition may
give rise to complex interactions between nucleosome remod-
eling activity and histone modification activity to coordinately
regulate gene expression.
A common element of NRCs is that their activity is not
instructive, but rather establishes either permissive or restric-
tive environments for developmental gene expression. It has
been suggested that NuRD complexes are critical in maintaining
pluripotency in embryonic stem cells (Crook et al., 2006). The
repressive role of NuRD may be critical in maintaining a molec-
ular brake on determinant genes. Recent work has shown that
functional NuRD is necessary for suppressing Elf5 and Eomes,
initial trophectoderm determinant genes, in a DNAmethylation-
dependent manner (Latos et al., 2012). While SWI/SNF com-
plexes seem to function as positive regulators of gene expression,
NuRD complexes function to maintain selective gene repression
throughout development and in the adult.
Human Exome Sequencing Implicates
BAF-Related Proteins in Developmental
Disorders
NRCs, particularly SWI/SNF, are well conserved throughout
mammalian and human cells (Table 1, Figure 1). The human
homologs of the yeast NRCs have similar critical roles in regu-
lating functional and developmental gene expression in higher
order mammals, including humans. Recently, research efforts
have examined the human genome, through both genome-wide
association studies and human exome sequencing. These new
sequencing efforts have led to the discovery of several mutations
in genes coding for nBAF subunits that are believed to be causal
mechanisms giving rise to various ID disorders, ASD, and other
developmental disorders. The majority of mutations have been
found in the SMARC and ARID families of genes, which code
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Backx et al., 2011;
Nord et al., 2011;
Halgren et al., 2012;
Hoyer et al., 2012
SMARC SWI2,
ISNF2
SMARCA2 NBS, SZ Koga et al., 2009; Van
Houdt et al., 2012;
Wolff et al., 2012





Santen et al., 2012a,b,
2013; Tsurusaki et al.,
2012, 2014; Staahl and
Crabtree, 2013; Miyake
et al., 2014
SWI3 SMARCC1 ASD Neale et al., 2012
SMARCC2 ASD Neale et al., 2012
SMARCE1 css Tsurusaki et al., 2012,
2014
CREST CREST sz Chesi et al., 2013
Adapted from and Staahl and Crabtree (2013) and Collingwood et al. (1999). ASD,
Austism Spectral Disorder; CSS, Coffin-Siris Syndrome; ID, Intellectual Disability; NBS,
Nicolaides-Baraitser Syndrome; SZ, Schizophrenia.
proteins of the nBAF complex (Hargreaves and Crabtree, 2011;
Wilson and Roberts, 2011; Santen et al., 2012b, 2013). SMARC
proteins are known to have helicase and ATPase activity and
are thought to be critical in nucleosome remodeling. In con-
trast, ARID proteins have DNA recognition binding sites and are
thought to give BAF complexes gene specificity. Coffin-Siris Syn-
drome (CSS), an ID disorder, may be caused by variousmutations
in ARID and SMARC genes (Table 1, Figure 2). First reported in
1970 by Drs. Coffin and Siris, CSS is characterized by ID and joint
abnormality, particularly in the fifth digit (Coffin and Siris, 1970).
Mutations in ARID1B have been found in patients showing agen-
esis of corpus callosum, intellectual disorder, speech impairment,
and varying degrees of autism severity (Halgren et al., 2012).
ARID1Bmutations have also been found in several patients diag-
nosed with CSS, along with mutations in ARID1A and several
SMARC genes including SMARCA4, SMARCA2, SMARCE1, and
SMARCB1 (Santen et al., 2012a; Tsurusaki et al., 2012; Parikshak
et al., 2013; Miyake et al., 2014).
Several BAF complex genes have also been implicated
with Nicolaides-Baraitser syndrome (NBS) (Table 1, Figure 2).
Patients with NBS are characterized by severe mental retardation,
seizures, and limited speech (Nicolaides and Baraitser, 1993).
Sequencing studies have discovered mutations in SMARCA2
in NBS patients and patients with intellectual disorders, along
with mutations in ARID1B and SMARCB1 (Van Houdt et al.,
FIGURE 1 | Proposed model of the nBAF complex. Subunits in white are
subunits thought to be neuron-specific. Adapted from Staahl and Crabtree
(2013).
2012; Santen et al., 2013; Miyake et al., 2014). Additionally,
mutations have been discovered in ADNP. Although not consid-
ered a subunit of the BAF complex, ADNP is known to inter-
act with several of the core BAF subunits, such as SMARCA4,
SMARCC2, and ARID1A (Mandel and Gozes, 2007). These
discovered mutations are thought to be causally related to devel-
opment of CSS and perhaps even de novo mutations in ASD
(Ben-David and Shifman, 2012; Helsmoortel et al., 2014; Van-
deweyer et al., 2014). Although the same genes (e.g., SMARC
genes) are implicated in different ID disorders, this is likely due to
when during development the mutation occurred, as well as cell
type-specific effects. A main characteristic of NRCs is the numer-
ous subunits, including cell type-specific subunits (as observed in
the neuron-specific nBAF genes described below), which give rise
to combinations that are developmental stage-specific and cell
type-specific. This is also quite likely why similar complexes have
roles in the adult brain related to cognition that are independent
from their developmental roles.
For example, research on CBP has demonstrated a clear role
for CBP in development as well as adult brain cognitive processes.
There are debates in the literature whether RTS was primarily
caused by loss of one allele of CBP, leading to a heterozygous
condition (Tanaka et al., 1997), or mutations and deletions giv-
ing rise to dominant negative alleles of CBP (Oike et al., 1999; see
Barrett and Wood, 2008 for review). Although that debate con-
tinues, researchers have been able to address a different question:
whether CBP has a role in adult cognition that is independent of
its role in development. This is an important question because if
CBP does have an independent role in adult cognition, it may be
possible one day to treat cognitive impairments associated with
mutations in CBP. Three early studies addressed this question
by demonstrating that indeed CBP has a role in adult cognition,
specifically with regard to long-lasting forms of synaptic plas-
ticity and long-term memory formation (Alarcón et al., 2004;
Korzus et al., 2004; Wood et al., 2005; Barrett et al., 2011). One
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FIGURE 2 | Exploded view of nBAF complex. Mammalian subunits associated with neuro developmental and/or cognitive disorders are in blue. Human gene
name is also included below subunit name. Mammalian subunits in gray have no currently known mutations linked with new:odevelopment or adult cognition.
idea to ameliorate cognitive impairments in genetically modi-
fied Cbpmutant mice was to use HDAC inhibitors, which would
effectively increase histone acetylation. Simply blocking HDAC
activity shouldn’t a priori result in an increase in histone acetyla-
tion, yet that is what is observed in nearly all studies (reviewed in
McQuown and Wood, 2011), suggesting that there is a dynamic
interplay between HDACs and HATs. Thus, removal of HDAC
activity allows for HATs to engage and increase histone acetyla-
tion. Interestingly, in some forms of synaptic plasticity andmem-
ory, HDAC inhibition enhances memory in a CBP-dependent
manner, which brings into question the ability to use HDAC inhi-
bition as a blanket treatment for RTS patients (Vecsey et al., 2007;
Barrett et al., 2011; Haettig et al., 2011).
BAF Complexes in Neural Development
The SWI/SNF family of nucleosome remodelers are well con-
served from yeast to mammals. BRG1/Brm-associated fac-
tor (BAF), homologous to SWI/SNF in yeast and brahma in
drosophila, is one such complex. In contrast to the SWI/SNF
complex, the specific functions of the BAF complex remain
unknown, yet are presumed to be similar. The various mech-
anisms of nucleosome remodeling employed by NRCs have
been thoroughly reviewed (Li et al., 2007; Bartholomew, 2014).
Although the nucleosome remodeling functions of BAF remain
unclear, BAF has been shown to be critical in cellular devel-
opment, particularly in regulated gene expression throughout
mitosis. With regards to mammalian development, there is a
neuron-specific NRC with functional roles in both neural devel-
opment and adult cognition. Neuron-specific BAF (nBAF) has
three dedicated subunits differentiating it from BAF: BAF53b,
BAF45b, and BAF45c (Figure 1). The exchange of these subunits
with their non-neuronal analogs is a critical switch in neu-
ral development and differentiates neural progenitor BAF from
nBAF (Olave et al., 2002; Hargreaves and Crabtree, 2011). Of
particular importance is the dedicated neuron-specific subunit
BAF53b. BAF53b expression begins at E12.5 and is exclusive to
post-mitotic neurons; it is not found in other epidermal tissue
(Olave et al., 2002; Bao et al., 2012). It has been shown that
the regulatory switch of upregulating BAF53b, BAF45b, and
BAF45c, while repressing expression of BAF53a, is critical in
establishing neural cell fate and is the final step in generating
post-mitotic neurons (Olave et al., 2002; Lessard et al., 2007;
Hargreaves and Crabtree, 2011). When BAF53b expression is
inhibited, or, conversely, when BAF53a expression is maintained,
neural differentiation is prevented (Hargreaves and Crabtree,
2011). The conversion from BAF53a to BAF53b is a vital switch
for neuronal development that has critical implications for adult
cognition.
Functionally, BAF53b has been shown to associate with BRG1,
both in vivo and in vitro, and is necessary for BRG1’s ATPase
function in neurons (Zhao et al., 1998; Olave et al., 2002). Cul-
tured neurons with BAF53b deletions show a loss of activity-
dependent dendritic growth that is restored with exogenous
expression of BAF53b. Moreover, deletions of Baf53b in mice
are lethal (Wu et al., 2007). However, BAF53b is not required
for the complete formation of the nBAF complex and does not
have independent ATPase function (Zhao et al., 1998; Olave
et al., 2002; Wu et al., 2007). This suggests that BAF53b may
not directly alter nBAF’s enzymatic activity, but as an actin-
related protein, may serve a scaffolding function for the recruit-
ment of additional subunits that help target the complex to spe-
cific gene promoters. One such subunit is the calcium-responsive
transactivator (CREST). CREST is known to regulate dendritic
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arborization and form a neuron-specific complex with nBAF
(Aizawa, 2004; Wu et al., 2007). Related work has shown that
BAF53b is necessary for the recruitment of the nBAF/CREST
complex to particular gene promoters, including Ephexin1, a
GTPase critical for synapse remodeling and maturation (Wu
et al., 2007; Shi et al., 2010a,b). Lastly, nBAF has been shown
to have a role in neural subtype specificity. For example, the
nBAF complex is known to regulate Sem-4. SEM-4 consists
of various zinc fingers and has been shown to be required
for both neuronal and mesodermal cellular development. The
zinc-fingers are thought to differentiate SEM-4’s roles in neu-
ral development from its roles in mesodermal development
(Basson and Horvitz, 1996). When Ham-3 specific mutations
are introduced, loss of BAF-dependent control of Sem-4 leads
to dysregulation of serotonergic neuronal cell fate (Weinberg
et al., 2013). HAM-3, a Striatin homolog, is part of the STRI-
PAK complex needed for MAP kinase regulation (Dettmann
et al., 2013; Hwang and Pallas, 2014). The above research
indicates that nBAF has a role in initiating neural differen-
tiation and regulating neural development. What about adult
cognition?
BAF Complexes in Cognition
The next questions are what makes BAF53b functionally unique
from its progenitor analog, BAF53a, do these functional dif-
ferences give rise to selective gene expression, and are the
roles of these discretely regulated genes in development (which
mutations give rise to developmental disorders) distinguish-
able from their roles in adult cognition. We recently published
a study that used two different genetically modified BAF53b
mutant mice that allowed us to begin addressing these questions
(Vogel-Ciernia et al., 2013). One transgenic animal was gener-
ated to target the hydrophobic domain, responsible for protein-
protein interactions, of BAF53b (BAF53b1HD mice). Deletions
of the hydrophobic domain in BAF53a are known to gener-
ate dominant-negative forms of BAF53a (Park et al., 2002) and
predicted to have a similar effect in BAF53b. The other ani-
mal was a conventional heterozygous mouse BAF53b+/− mice;
generated by Dr. Gerald Crabtree’s lab, (Wu et al., 2007)). Both
BAF53b+/− and BAF53b1HD animals exhibited large impair-
ments in long-term memory formation in the object location
memory (OLM) task (Vogel-Ciernia et al., 2013). This deficit
was rescued in BAF53b+/− by acutely restoring expression of
BAF53b to the dorsal hippocampus, a region known to be nec-
essary for the OLM task (Stefanko et al., 2009; Haettig et al., 2011;
McQuown et al., 2011; Vogel-Ciernia et al., 2013). Together, these
results suggest that BAF53b is necessary and sufficient for the
formation of long-term memory.
Importantly, the hydrophobic domain is not a unique
subdomain to differentiate BAF53a from BAF53b. Although
BAF53b and BAF53a are structurally similar, the most diver-
gent region is subdomain 2. Subdomain 2 is required for
the BAF53b-dependent dendritic outgrowth seen in cultured
neurons (Wu et al., 2007). To evaluate the role of BAF53b’s
Subdomain 2 and how it differs from BAF53a’s Subdomain
2, Wu et al. (2007) created chimeric versions of BAF53a
and BAF53b, interchanging their respective Subdomain 2. The
chimeric BAF53a (containing BAF53b’s Subdomain 2) was able to
restore the dendritic branching of BAF53b−/− neuronal cultures,
while also restoring BAF53b-dependent expression of Ephexin
and Gap43. However, the inverse chimera (BAF53b containing
BAF53a’s Subdomain 2) was unable to rescue the loss of den-
dritic growth and gene expression (Wu et al., 2007). These crit-
ical experiments show that it is Subdomain 2 of BAF53b that is
necessary for neuronal development and neuron-specific gene
expression. Thus, Subdomain 2 is the key domain that differ-
entiates the function of BAF53b from the function of BAF53a.
Additionally, BAF53b is one of the neuron-specific subunits of
nBAF, and BAF53b is a dedicated subunit of the nBAF complex
(thus not found in other complexes, as far as the field understands
at this point), which makes the BAF53b Subdomain 2 an ideal
target to study the neuronal function of BAF53b in adult synap-
tic plasticity and memory formation. It will be very important to
understand the role of BAF53b Subdomain 2 in cognition and
also determine whether Subdomain 2 has unique protein-protein
interactions, phosphorylation sites, etc. Subdomain 2 may pro-
vide critical insight into understanding the neuron-specific role
of nBAF in adult cognition.
Enhanceosome
As previously discussed, it is critical to understand the dynamics
of these gene regulatory mechanisms. In order to do so, we must
understand that these epigenetic mechanisms occur, both spa-
tially and temporally, in conjunction with each other and other
gene regulatory elements. One element, which also recruits pro-
tein complexes to control gene expression, is the enhanceosome.
Enhanceosomes refer to the transcription factor complexes that
assemble and bind to gene enhancers and recruit other modifying
enzymes (Thanos and Maniatis, 1995; Merika and Thanos, 2001;
Panne, 2008). The assembly of particular transcription factors
in such a manner allows for a gene-specific level of regulation.
One well-studied enhanceosome system regulates interferon-β
(Ifnβ) gene expression. The chromatin surrounding Ifnβ is typ-
ically compressed, while its enhancer element remains exposed
between nucleosomes. Ifnβ expression is relatively suppressed;
upon exposure to viral infection, its expression dramatically
increases through the assembly of a particular enhanceosome
complex to the Ifnβ enhancer. This complex is able to selec-
tively recruit histone acetyltransferases (such as CBP and p300)
to nearby chromatin, leading to histone acetylation and SWI/SNF
complex recruitment (Merika et al., 1998; Yie et al., 1999; Agalioti
et al., 2000; Koutroubas et al., 2008).
This form of gene regulation is not unique to Ifnβ expression.
Several eukaryotic genes have been shown to be regulated in
a similar fashion, including Elam-1, Hmg-1, Interleukin-6, and
Interleukin-2 (Whitley et al., 1994; John et al., 1995; Vanden
Berghe et al., 1999; Ellwood et al., 2000; Merika and Thanos,
2001). The dynamic and conjunctive activity of these enzymes,
activating NRCs, generate a more permissive state allowing basic
transcription factors access to the respective genes of inter-
est (Kim and Maniatis, 1997; Agalioti et al., 2000; Merika and
Thanos, 2001). Yet, enhanceosome-mediated gene regulation
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in the nervous system has received relatively little attention.
With the crucial role nucleosome remodeling complexes have
in proper nervous system function, enhanceosomes may be as
important in regulating the proper gene expression in processes
from neural development to long-term memory formation.
Conclusion
In this review we have focused on the role of nucleosome
remodeling in development and adult cognition. Several human
sequencing studies have shown that mutations in the genes
making up the BAF complex in particular may give rise to
distinct ID disorders including CSS, NBS, and ASD. These
human studies highlight how critically important nucleosome
remodeling is for proper development and cognitive function.
One central theme we discussed was the role of nucleosome
remodeling in development and whether that role is inde-
pendent of a role for nucleosome remodeling in adult cogni-
tion. That question can only be understood by studying the
role of nucleosome remodeling in model organisms. Indeed,
research has demonstrated for several epigenetic regulatory
enzymes (e.g., CBP) and DNA methylation binding proteins
(e.g., MeCP2) and more recently for nucleosome remodeling
(e.g., BAF53b), that these factors have a role in adult neu-
ronal plasticity, learning, and memory, independent of their
developmental roles. It remains difficult to prove that this is
also the case in adult ID disorders associated with mutations
in these genes, but it gives hope that cognitive dysfunction
observed in these ID disorders may one day be at least partially
ameliorated.
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